Praxis Precision Medicines Inc. (NASDAQ: PRAX) started the day on March 15, 2023, with a price increase of 0.88% at $1.14. During the day, the stock rose to $1.155 and sunk to $1.085 before settling in for the price of $1.13 at the close. Taking a more long-term approach, PRAX posted a 52-week range of $0.98-$13.33.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -18.00%. This publicly-traded company’s shares outstanding now amounts to $47.61 million, simultaneously with a float of $46.80 million. The organization now has a market capitalization sitting at $58.62 million. At the time of writing, stock’s 50-day Moving Average stood at $3.2668, while the 200-day Moving Average is $2.9299.
Praxis Precision Medicines Inc. (PRAX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Praxis Precision Medicines Inc.’s current insider ownership accounts for 0.60%, in contrast to 90.30% institutional ownership. According to the most recent insider trade that took place on Jun 16, this organization’s Principal Accounting Officer bought 3,000 shares at the rate of 1.93, making the entire transaction reach 5,775 in total value, affecting insider ownership by 31,391. Preceding that transaction, on Jun 13, Company’s General Counsel and Secretary bought 7,500 for 1.63, making the whole transaction’s value amount to 12,225. This particular insider is now the holder of 39,347 in total.
Praxis Precision Medicines Inc. (PRAX) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 12/30/2022, the organization reported -$0.87 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.78) by -$0.09. This company achieved a return on equity of -130.94. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.73 per share during the current fiscal year.
Praxis Precision Medicines Inc.’s EPS decrease for this current 12-month fiscal period is -18.00% and is forecasted to reach -2.77 in the upcoming year.
Praxis Precision Medicines Inc. (NASDAQ: PRAX) Trading Performance Indicators
Let’s observe the current performance indicators for Praxis Precision Medicines Inc. (PRAX). It’s Quick Ratio in the last reported quarter now stands at 3.20. The Stock has managed to achieve an average true range (ATR) of 0.27.
In the same vein, PRAX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.66, a figure that is expected to reach -0.71 in the next quarter, and analysts are predicting that it will be -2.77 at the market close of one year from today.
Technical Analysis of Praxis Precision Medicines Inc. (PRAX)
If we take a close look at the recent performances of Praxis Precision Medicines Inc. (NASDAQ: PRAX), its last 5-days Average volume was 2.46 million that shows progress from its year to date volume of 2.3 million. During the previous 9 days, stock’s Stochastic %D was recorded 13.11% While, its Average True Range was 0.2301.
Raw Stochastic average of Praxis Precision Medicines Inc. (PRAX) in the period of the previous 100 days is set at 3.72%, which indicates a major fall in contrast to 6.29% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 442.86% that was higher than 192.06% volatility it exhibited in the past 100-days period.